ReWalk Robotics Ltd. (NASDAQ:RWLK)’s share price dropped 4.1% on Wednesday . The company traded as low as $5.63 and last traded at $5.68, with a volume of 62,272 shares traded. The stock had previously closed at $5.92.

RWLK has been the topic of a number of recent research reports. Zacks Investment Research lowered ReWalk Robotics from a “buy” rating to a “hold” rating in a research note on Thursday, July 7th. Piper Jaffray Cos. initiated coverage on ReWalk Robotics in a research note on Friday, July 15th. They set an “overweight” rating and a $10.00 price objective on the stock. Finally, Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a research note on Sunday, August 7th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. ReWalk Robotics presently has an average rating of “Buy” and an average target price of $12.80.

The firm’s market cap is $70.90 million. The company’s 50 day moving average price is $6.13 and its 200-day moving average price is $7.67.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/rewalk-robotics-ltd-rwlk-trading-down-4-1.html

ReWalk Robotics (NASDAQ:RWLK) last issued its earnings results on Thursday, August 4th. The medical device company reported ($0.64) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.53) by $0.11. The business had revenue of $0.82 million for the quarter, compared to analysts’ expectations of $1.95 million. ReWalk Robotics had a negative return on equity of 163.18% and a negative net margin of 556.61%. ReWalk Robotics’s revenue for the quarter was up 34.4% on a year-over-year basis. Analysts expect that ReWalk Robotics Ltd. will post ($2.34) EPS for the current fiscal year.

In other news, major shareholder Scp Vitalife Partners (Israel) sold 25,038 shares of the stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $6.37, for a total transaction of $159,492.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Wayne Weisman sold 100,000 shares of the stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $6.37, for a total value of $637,000.00. The disclosure for this sale can be found here. Insiders own 17.70% of the company’s stock.

A hedge fund recently bought a new stake in ReWalk Robotics stock. A.R.T. Advisors LLC acquired a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 20,711 shares of the medical device company’s stock, valued at approximately $134,000. A.R.T. Advisors LLC owned approximately 0.17% of ReWalk Robotics as of its most recent SEC filing. Institutional investors own 4.91% of the company’s stock.

About ReWalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

5 Day Chart for NASDAQ:RWLK

Receive News & Ratings for ReWalk Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.